Clinical Trial Update: Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon [Phase 4]

View source ↗

Summary

A Phase 4 trial update reports completion of a study to determine the appropriate initial dosing of phenprocoumon in patients with pulmonary embolism or atrial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Pulmonary Embolism

Drugs mentioned

• Phenprocoumon (phenprocoumon)

Snippet

Sponsor: Cantonal Hospital of St. Gallen | Conditions: Pulmonary Embolism, Atrial Fibrillation | Phase 4 | Status: COMPLETED